---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-003815"
form_type: "8-K"
ticker: "ONCY"
cik: "0001129928"
company_name: "ONCOLYTICS BIOTECH INC"
filed_at: "2026-01-15T23:59:59+00:00"
generated_at: "2026-05-16T10:04:11.527819+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Oncolytics appoints EVP John McAdory and VP Biostatistics Yujun Wu, grants inducement awards

## Summary
- John McAdory named EVP Strategy & Operations; previously VP Clinical Ops at CG Oncology (Nasdaq: CGON).
- Yujun Wu named VP Head of Biostatistics; previously Head of Biostatistics at Morphic Therapeutic.
- Inducement awards: McAdory 500k options + 300k RSUs; Wu 300k options; exercise price $0.97.
- Appointments enhance execution for late-stage pancreatic, colorectal, and anal cancer trials.

## SEC filing metadata
- accession: 0001104659-26-003815
- form_type: 8-K
- ticker: ONCY
- cik: 0001129928
- company_name: ONCOLYTICS BIOTECH INC
- filed_at: 2026-01-15T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1129928/000110465926003815/0001104659-26-003815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1129928/000110465926003815/tm263244d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-003815
- JSON: https://secwatch.observer/filing/0001104659-26-003815.json
- Plain text: https://secwatch.observer/filing/0001104659-26-003815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.